---
title: "Cresco Labs Inc. (CRLBF.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/CRLBF.US.md"
symbol: "CRLBF.US"
name: "Cresco Labs Inc."
industry: "Pharmaceuticals"
datetime: "2026-05-19T17:16:48.918Z"
locales:
  - [en](https://longbridge.com/en/quote/CRLBF.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CRLBF.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CRLBF.US.md)
---

# Cresco Labs Inc. (CRLBF.US)

## Company Overview

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections and fruit-forward gummies under the Mindy’s Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts.

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | US Market |
| Website | [www.crescolabs.com](https://www.crescolabs.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: D
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:13.000Z

**Overall: D (0.72)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 138 / 190 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: D

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -8.02% |  |
| Net Profit YoY | -60.20% |  |
| P/B Ratio | 1.19 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 398245696.76 |  |
| Revenue | 641415000.00 |  |

#### Multi Score Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -33.60% | E |
| Profit Margin | -20.90% | D |
| Gross Margin | 49.86% | B |
| Revenue YoY | -8.02% | D |
| Net Profit YoY | -60.20% | D |
| Total Assets YoY | -12.11% | E |
| Net Assets YoY | -34.98% | E |
| Cash Flow Margin | -27.45% | E |
| OCF YoY | -8.02% | D |
| Turnover | 0.50 | C |
| Gearing Ratio | 79.63% | E |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Cresco Labs Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-8.02%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-60.20%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.19",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "398245696.76",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "641415000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-33.60%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-20.90%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "49.86%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "-8.02%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "-60.20%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "-12.11%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-34.98%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-27.45%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "-8.02%",
          "rating": "D"
        },
        {
          "name": "Turnover",
          "value": "0.50",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "79.63%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -2.97 | 147/190 | - | - | - |
| PB | 1.19 | 56/190 | 1.31 | 1.12 | 0.65 |
| PS (TTM) | 0.62 | 23/190 | 0.81 | 0.66 | 0.43 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Cormedix (CRMD.US) | A | A | B | C | B | A |
| 02 | Eli Lilly (LLY.US) | A | A | B | D | B | B |
| 03 | ROCHE HOLDINGS AG (RHHVF.US) | A | B | B | D | B | B |
| 04 | Roche (RHHBY.US) | A | B | B | D | B | B |
| 05 | AstraZeneca (AZN.US) | A | B | C | D | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-11T04:00:00.000Z

Total Analysts: **7**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 6 | 86% |
| Overweight | 1 | 14% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.84 |
| Highest Target | 2.00 |
| Lowest Target | 2.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/CRLBF.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/CRLBF.US/norm.md)
- [Related News](https://longbridge.com/en/quote/CRLBF.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/CRLBF.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**